Literature DB >> 11220767

Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment.

A Schuetz1, D G Addiss, M L Eberhard, P J Lammie.   

Abstract

The immunochromatographic (ICT) filariasis test is a rapid screening tool that will be useful for defining the prevalence and distribution of Wuchereria bancrofti as part of the global program to eliminate lymphatic filariasis. To address questions about its usefulness for monitoring control programs, we used the ICT filariasis test to assess residual antigen levels following antifilarial treatment. Our results demonstrate that antigen levels persist in microfilaria-negative persons for up to three years after treatment. Different strategies for monitoring control programs may have to be considered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11220767     DOI: 10.4269/ajtmh.2000.62.502

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Low density microfilaraemia as a causative agent in a case of unexplained ascitis of suspicious nature.

Authors:  Rahul Mannan; Tejinder Singh Bhasin; Mridu Manjari; Vatsala Misra
Journal:  J Clin Diagn Res       Date:  2013-07-01

2.  Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen.

Authors:  Cédric B Chesnais; François Missamou; Sébastien D S Pion; Jean Bopda; Frédéric Louya; Andrew C Majewski; Gary J Weil; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

3.  Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.

Authors:  Nilima A Kshirsagar; N J Gogtay; B S Garg; P R Deshmukh; D D Rajgor; V S Kadam; P A Thakur; A Gupta; N S Ingole; J K Lazdins-Helds
Journal:  Parasitol Res       Date:  2017-08-07       Impact factor: 2.289

4.  Elimination of lymphatic filariasis in the Gambia.

Authors:  Maria P Rebollo; Sana Malang Sambou; Brent Thomas; Nana-Kwadwo Biritwum; Momodou C Jaye; Louise Kelly-Hope; Alba Gonzalez Escalada; David H Molyneux; Moses J Bockarie
Journal:  PLoS Negl Trop Dis       Date:  2015-03-18

5.  Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination.

Authors:  Hugues C Nana-Djeunga; Jules B Tchatchueng-Mbougua; Jean Bopda; Steve Mbickmen-Tchana; Nathalie Elong-Kana; Etienne Nnomzo'o; Julie Akame; Ann Tarini; Yaobi Zhang; Flobert Njiokou; Joseph Kamgno
Journal:  PLoS Negl Trop Dis       Date:  2015-09-09

6.  Backpack PCR: A point-of-collection diagnostic platform for the rapid detection of Brugia parasites in mosquitoes.

Authors:  Weam I Zaky; Francesca R Tomaino; Nils Pilotte; Sandra J Laney; Steven A Williams
Journal:  PLoS Negl Trop Dis       Date:  2018-11-21

7.  Monitoring and evaluation of lymphatic filariasis interventions: an improved PCR-based pool screening method for high throughput Wuchereria bancrofti detection using dried blood spots.

Authors:  Catherine Plichart; Aurore Lemoine
Journal:  Parasit Vectors       Date:  2013-04-18       Impact factor: 3.876

8.  Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.

Authors:  Raceline Gounoue-Kamkumo; Hugues C Nana-Djeunga; Jean Bopda; Julie Akame; Ann Tarini; Joseph Kamgno
Journal:  BMC Infect Dis       Date:  2015-12-23       Impact factor: 3.090

Review 9.  Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.

Authors:  Yuan Fang; Yi Zhang
Journal:  Infect Dis Poverty       Date:  2019-08-07       Impact factor: 10.485

10.  Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA).

Authors:  Benjamin S Collyer; Michael A Irvine; T Deidre Hollingsworth; Mark Bradley; Roy M Anderson
Journal:  PLoS Negl Trop Dis       Date:  2020-10-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.